Hervé Affagard, CEO and co-founder of MaaT Pharma, commented on the first FDA-approval for a…
MaaT PharmaDecember 2, 2022
2022 edition of HealthTech Innovation Days: replay of "Translational microbiome medicine to treat serious oncology…
MaaT PharmaOctober 21, 2022
Interview of Hervé Affagard, CEO and co-founder of MaaT Pharma, for Lyon Décideurs - Bourses…
MaaT PharmaOctober 18, 2022
La Bourse et la Vie interviewed Hervé Affagard, CEO and co-founder of MaaT Pharma, during…
MaaT PharmaOctober 13, 2022
Interview of Hervé Affagard published in the July-August 2022 edition of MedNous, a business-science publication…
MaaT PharmaJuly 22, 2022
Dive into the micobiome revolution with Dr. Joël Doré, INRAE Research Director, Scientific Director of…
MaaT PharmaJune 27, 2022